Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas.

Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, Yamane A, Kaira K, Yokobori T, Nagashima T, Obayashi K, Nakazawa S, Iijima M, Kosaka T, Yajima T, Mogi A, Kuwano H, Shirabe K, Nishiyama M.

Oncotarget. 2019 Feb 12;10(13):1306-1319. doi: 10.18632/oncotarget.26657. eCollection 2019 Feb 12.

2.

High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.

Bao H, Bai T, Takata K, Yokobori T, Ohnaga T, Hisada T, Maeno T, Bao P, Yoshida T, Kumakura Y, Honjo H, Sakai M, Sohda M, Fukuchi M, Altan B, Handa T, Ide M, Miyazaki T, Ogata K, Oyama T, Shimizu K, Mogi A, Asao T, Shirabe K, Kuwano H, Kaira K.

Oncol Lett. 2018 Mar;15(3):3061-3067. doi: 10.3892/ol.2017.7671. Epub 2017 Dec 20.

3.

Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.

Ishii N, Araki K, Yokobori T, Gantumur D, Yamanaka T, Altan B, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Hosouchi Y, Kuwano H, Shirabe K.

Oncotarget. 2017 Nov 6;8(68):112636-112646. doi: 10.18632/oncotarget.22634. eCollection 2017 Dec 22.

4.

Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.

Kimura A, Ogata K, Altan B, Yokobori T, Mochiki E, Yanai M, Kogure N, Yanoma T, Suzuki M, Bai T, Kuwano H.

World J Gastroenterol. 2017 Nov 14;23(42):7541-7550. doi: 10.3748/wjg.v23.i42.7541.

5.

Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma.

Altan B, Kaira K, Watanabe A, Kubo N, Bao P, Dolgormaa G, Bilguun EO, Araki K, Kanai Y, Yokobori T, Oyama T, Nishiyama M, Kuwano H, Shirabe K.

Cancer Chemother Pharmacol. 2018 Jan;81(1):141-153. doi: 10.1007/s00280-017-3477-4. Epub 2017 Nov 17.

PMID:
29149426
6.

High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.

Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H.

Ann Surg Oncol. 2017 Dec;24(13):4017-4024. doi: 10.1245/s10434-017-6083-0. Epub 2017 Sep 20.

PMID:
28933054
7.

Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.

Kumakura Y, Rokudai S, Iijima M, Altan B, Yoshida T, Bao H, Yokobori T, Sakai M, Sohda M, Miyazaki T, Nishiyama M, Kuwano H.

Cancer Sci. 2017 Nov;108(11):2149-2155. doi: 10.1111/cas.13394. Epub 2017 Oct 3.

8.

Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma.

Ogawa H, Kaira K, Takahashi K, Shimizu A, Altan B, Yoshinari D, Asao T, Oyama T.

Cancer Biomark. 2017 Sep 7;20(3):273-281. doi: 10.3233/CBM-170062.

PMID:
28854502
9.

Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC.

Kaira K, Higuchi T, Naruse I, Arisaka Y, Tokue A, Altan B, Suda S, Mogi A, Shimizu K, Sunaga N, Hisada T, Kitano S, Obinata H, Yokobori T, Mori K, Nishiyama M, Tsushima Y, Asao T.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):56-66. doi: 10.1007/s00259-017-3806-1. Epub 2017 Aug 21.

PMID:
28828507
10.

Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.

Obayashi S, Horiguchi J, Higuchi T, Katayama A, Handa T, Altan B, Bai T, Bao P, Bao H, Yokobori T, Nishiyama M, Oyama T, Kuwano H.

Int J Oncol. 2017 Sep;51(3):781-790. doi: 10.3892/ijo.2017.4085. Epub 2017 Jul 27.

11.

High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.

Altan B, Kaira K, Okada S, Saito T, Yamada E, Bao H, Bao P, Takahashi K, Yokobori T, Tetsunari O, Nishiyama M, Yamada M.

Tumour Biol. 2017 Jul;39(7):1010428317703817. doi: 10.1177/1010428317703817.

PMID:
28714371
12.

Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.

Handa T, Katayama A, Yokobori T, Yamane A, Horiguchi J, Kawabata-Iwakawa R, Rokudai S, Bao P, Gombodorj N, Altan B, Kaira K, Asao T, Kuwano H, Nishiyama M, Oyama T.

J Surg Oncol. 2017 Nov;116(6):706-715. doi: 10.1002/jso.24705. Epub 2017 Jun 1.

PMID:
28570747
13.

Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.

Ishii N, Araki K, Yokobori T, Watanabe A, Tsukagoshi M, Kubo N, Suzuki H, Saito F, Altan B, Hosouchi Y, Shirabe K, Kuwano H.

Oncol Lett. 2017 May;13(5):3653-3661. doi: 10.3892/ol.2017.5946. Epub 2017 Mar 29.

14.

Enhanced karyopherin-α2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms.

Kubo N, Araki K, Altan B, Hoshino K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kato T, Hirai K, Yokobori T, Saito F, Suzuki H, Kuwano H, Shirabe K.

Pancreatology. 2017 Jul - Aug;17(4):611-616. doi: 10.1016/j.pan.2017.04.011. Epub 2017 Apr 23.

PMID:
28476582
15.

Prognostic impact of stathmin 1 expression in patients with lung adenocarcinoma.

Shimizu K, Ohtaki Y, Altan B, Yokobori T, Nagashima T, Arai M, Mogi A, Kuwano H.

J Thorac Cardiovasc Surg. 2017 Oct;154(4):1406-1417.e3. doi: 10.1016/j.jtcvs.2017.03.125. Epub 2017 Apr 5.

16.

Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms.

Watanabe A, Araki K, Yokobori T, Altan B, Ishii N, Tsukagoshi M, Kubo N, Saito F, Suzuki H, Kuwano H.

Oncol Lett. 2017 Mar;13(3):1783-1788. doi: 10.3892/ol.2017.5603. Epub 2017 Jan 17.

17.

High stathmin 1 expression is associated with poor prognosis and chemoradiation resistance in esophageal squamous cell carcinoma.

Suzuki S, Yokobori T, Altan B, Hara K, Ozawa D, Tanaka N, Sakai M, Sano A, Sohda M, Bao H, Fukuchi M, Miyazaki T, Kaira K, Asao T, Kuwano H.

Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3899. [Epub ahead of print]

PMID:
28350065
18.

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.

Bai T, Yokobori T, Altan B, Ide M, Mochiki E, Yanai M, Kimura A, Kogure N, Yanoma T, Suzuki M, Bao P, Kaira K, Asao T, Katayama A, Handa T, Gombodorj N, Nishiyama M, Oyama T, Ogata K, Kuwano H.

Br J Cancer. 2017 Apr 25;116(9):1177-1185. doi: 10.1038/bjc.2017.76. Epub 2017 Mar 23.

19.

Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.

Tsukagoshi M, Araki K, Yokobori T, Altan B, Suzuki H, Kubo N, Watanabe A, Ishii N, Hosouchi Y, Nishiyama M, Shirabe K, Kuwano H.

Oncotarget. 2017 Jun 27;8(26):42159-42172. doi: 10.18632/oncotarget.15020.

20.

Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression.

Igarashi T, Araki K, Yokobori T, Altan B, Yamanaka T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Handa T, Hosouchi Y, Nishiyama M, Oyama T, Shirabe K, Kuwano H.

Oncotarget. 2017 Feb 14;8(7):12290-12300. doi: 10.18632/oncotarget.14703.

21.

Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis.

Kogure N, Yokobori T, Ogata K, Altan B, Mochiki E, Ohno T, Toyomasu Y, Yanai M, Kimura A, Yanoma T, Suzuki M, Bai T, Asao T, Kuwano H.

Anticancer Res. 2017 Jan;37(1):191-196.

PMID:
28011490
22.

High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.

Altan B, Yokobori T, Ide M, Bai T, Yanoma T, Kimura A, Kogure N, Suzuki M, Bao P, Mochiki E, Ogata K, Handa T, Kaira K, Nishiyama M, Asao T, Oyama T, Kuwano H.

Anticancer Res. 2016 Oct;36(10):5237-5247.

PMID:
27798884
23.

Oculoauriculofrontonasal Dysplasia Syndrome With Additional Clinical Features.

Tunc T, Polat A, Altan B, Yapici AK, Saldir M, Sari S, Sari E, Bayram Y, Eski M.

Cleft Palate Craniofac J. 2017 Nov;54(6):749-753. doi: 10.1597/15-078. Epub 2016 Oct 10.

PMID:
27723380
24.

Elemental and immunohistochemical analysis of the lungs and hilar lymph node in a patient with asbestos exposure, a pilot study.

Koga Y, Satoh T, Kaira K, Koka M, Hisada T, Hirato J, Altan B, Yatomi M, Ono A, Kamide Y, Shimizu Y, Aoki-Saito H, Tsurumaki H, Shimizu K, Mogi A, Ishizuka T, Yamada M, Dobashi K.

Environ Health Prev Med. 2016 Nov;21(6):492-500. Epub 2016 Oct 3.

25.

High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.

Saito F, Araki K, Yokobori T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Altan B, Shirabe K, Kuwano H.

J Surg Oncol. 2016 Sep;114(4):462-8. doi: 10.1002/jso.24330. Epub 2016 Jun 23.

PMID:
27338241
26.

Cerebellopontine angle arachnoid cyst associated with mirror movements.

Gurkas E, Altan BY, Gücüyener K, Kolsal E.

J Pediatr Neurosci. 2015 Oct-Dec;10(4):371-3. doi: 10.4103/1817-1745.174440.

27.

Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.

Kimura A, Ogata K, Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Yanoma T, Suzuki M, Bai T, Oyama T, Kuwano H.

Oncotarget. 2016 Apr 5;7(14):18415-23. doi: 10.18632/oncotarget.7821.

28.

Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.

Tsukagoshi M, Wada S, Yokobori T, Altan B, Ishii N, Watanabe A, Kubo N, Saito F, Araki K, Suzuki H, Hosouchi Y, Kuwano H.

Cancer Sci. 2016 Feb;107(2):116-22. doi: 10.1111/cas.12853. Epub 2016 Feb 2.

29.

Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.

Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Kimura A, Hara K, Bai T, Bao P, Suzuki M, Ogata K, Asao T, Nishiyama M, Oyama T, Kuwano H.

Gastric Cancer. 2016 Jul;19(3):789-97. doi: 10.1007/s10120-015-0551-7. Epub 2015 Oct 15.

PMID:
26472729
30.

Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.

Yokobori T, Bao P, Fukuchi M, Altan B, Ozawa D, Rokudai S, Bai T, Kumakura Y, Honjo H, Hara K, Sakai M, Sohda M, Miyazaki T, Ide M, Nishiyama M, Oyama T, Kuwano H.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1566-73. doi: 10.1245/s10434-015-4831-6. Epub 2015 Aug 27.

PMID:
26310281
31.

SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer.

Azuma Y, Yokobori T, Mogi A, Altan B, Yajima T, Kosaka T, Onozato R, Yamaki E, Asao T, Nishiyama M, Kuwano H.

J Surg Oncol. 2015 Aug;112(2):231-7. doi: 10.1002/jso.23975. Epub 2015 Jul 15.

PMID:
26180037
32.

Src kinase-associated phosphoprotein2 expression is associated with poor prognosis in non-small cell lung cancer.

Kuranami S, Yokobori T, Mogi A, Altan B, Yajima T, Onozato R, Azuma Y, Iijima M, Kosaka T, Kuwano H.

Anticancer Res. 2015 Apr;35(4):2411-5.

PMID:
25862907
33.

Intestinal epithelial culture under an air-liquid interface: a tool for studying human and mouse esophagi.

Yokobori T, Suzuki S, Miyazaki T, Sohda M, Sakai M, Tanaka N, Ozawa D, Hara K, Honjo H, Altan B, Fukuchi M, Ishii H, Iwatsuki M, Sugimachi K, Sudo T, Iwaya T, Nishida N, Mimori K, Kuwano H, Mori M.

Dis Esophagus. 2016 Oct;29(7):843-847. doi: 10.1111/dote.12346. Epub 2015 Mar 23.

PMID:
25809505
34.

Metabolic and Histopathological Effects of Fructose Intake During Pregestation, Gestation and Lactation in Rats and their Offspring.

Sarı E, Yeşilkaya E, Bolat A, Topal T, Altan B, Fidancı K, Saldır M, Erdem G, Gülgün M, Kurt YG, Güven A.

J Clin Res Pediatr Endocrinol. 2015 Mar;7(1):19-26. doi: 10.4274/jcrpe.1776.

35.

MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.

Suto T, Yokobori T, Yajima R, Morita H, Fujii T, Yamaguchi S, Altan B, Tsutsumi S, Asao T, Kuwano H.

Carcinogenesis. 2015 Mar;36(3):338-45. doi: 10.1093/carcin/bgu242. Epub 2014 Dec 10.

PMID:
25503932
36.

Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.

Watanabe A, Suzuki H, Yokobori T, Tsukagoshi M, Altan B, Kubo N, Suzuki S, Araki K, Wada S, Kashiwabara K, Hosouchi Y, Kuwano H.

Cancer Sci. 2014 Jun;105(6):690-6. doi: 10.1111/cas.12417. Epub 2014 May 27.

37.

Blood group substances as potential therapeutic agents for the prevention and treatment of infection with noroviruses proving novel binding patterns in human tissues.

Yazawa S, Yokobori T, Ueta G, Ide M, Altan B, Thongprachum A, Nishimura T, Nakajima T, Kominato Y, Asao T, Saniabadi AR, Furukawa K, Kuwano H, Le Pendu J, Ushijima H.

PLoS One. 2014 Feb 18;9(2):e89071. doi: 10.1371/journal.pone.0089071. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e107825.

38.

FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.

Yokobori T, Yokoyama Y, Mogi A, Endoh H, Altan B, Kosaka T, Yamaki E, Yajima T, Tomizawa K, Azuma Y, Onozato R, Miyazaki T, Tanaka S, Kuwano H.

Mol Cancer Res. 2014 Jan;12(1):32-7. doi: 10.1158/1541-7786.MCR-13-0341. Epub 2013 Oct 28.

39.

Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.

Watanabe A, Suzuki H, Yokobori T, Altan B, Kubo N, Araki K, Wada S, Mochida Y, Sasaki S, Kashiwabara K, Hosouchi Y, Kuwano H.

Cancer Sci. 2013 Nov;104(11):1427-32. doi: 10.1111/cas.12249. Epub 2013 Sep 15.

40.

Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.

Altan B, Yokobori T, Mochiki E, Ohno T, Ogata K, Ogawa A, Yanai M, Kobayashi T, Luvsandagva B, Asao T, Kuwano H.

Carcinogenesis. 2013 Oct;34(10):2314-21. doi: 10.1093/carcin/bgt214. Epub 2013 Jun 8.

PMID:
23749771
41.

Does proclination of maxillary incisors really affect the sagittal position of point A?

Bicakci AA, Cankaya OS, Mertoglu S, Yilmaz N, Altan BK.

Angle Orthod. 2013 Nov;83(6):943-7. doi: 10.2319/021413-133.1. Epub 2013 May 16.

PMID:
23678998
42.

The relationship of orthodontic treatment need with periodontal status, dental caries, and sociodemographic factors.

Nalcaci R, Demirer S, Ozturk F, Altan BA, Sokucu O, Bostanci V.

ScientificWorldJournal. 2012;2012:498012. doi: 10.1100/2012/498012. Epub 2012 Oct 23.

43.

Systemic propolis stimulates new bone formation at the expanded suture: a histomorphometric study.

Altan BA, Kara IM, Nalcaci R, Ozan F, Erdogan SM, Ozkut MM, Inan S.

Angle Orthod. 2013 Mar;83(2):286-91. doi: 10.2319/032612-253.1. Epub 2012 Aug 20.

PMID:
22906401
44.

The treatment of an impacted mandibular canine: case report.

Altan B, Doruk C.

Int J Orthod Milwaukee. 2011 Winter;22(4):17-20.

PMID:
22360077
45.

Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement.

Altan BA, Sokucu O, Ozkut MM, Inan S.

Lasers Med Sci. 2012 Jan;27(1):131-40. doi: 10.1007/s10103-010-0853-2. Epub 2010 Oct 31.

PMID:
21038101
46.

Engineering and medical applications of diatoms.

Wee KM, Rogers TN, Altan BS, Hackney SA, Hamm C.

J Nanosci Nanotechnol. 2005 Jan;5(1):88-91. Review.

PMID:
15762165

Supplemental Content

Support Center